2030 Patients Safety 
Cannabis Law Report
JUNE 7, 2021
The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety.
Cannabis Law Report
JUNE 25, 2021
DUBLIN–(BUSINESS WIRE)–The “Skin Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030” report has been added to ResearchAndMarkets.com’s offering. The global skin cancer drugs market is expected to grow from $1.44 billion in 2020 to $1.61
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 7, 2021
The state’s medical patients (about 0.5% The state’s legalization law divides cannabis tax revenue into two funds, one to support public health initiatives and the other for public safety and law enforcement training. Those sales were taxed at 25% beginning January 4, 2016. Estimated State Sales Tax Revenue from Adult-Use Cannabis 23.
Cannabis Law Report
JANUARY 9, 2022
The state’s medical patients (about 0.5% The state’s legalization law divides cannabis tax revenue into two funds, one to support public health initiatives and the other for public safety and law enforcement training. Those sales were taxed at 25% beginning January 4, 2016. Maine State Sales Tax Revenue from Adult-Use Cannabis 23.
Cannabis Law Report
MARCH 25, 2019
Permits the distribution of medicinal marihuana only to hospitals and pharmacies registered to dispense Schedule II controlled substances for the purposes of treating glaucoma or the nausea of cancer patients or research approved under the Federal Food, Drug, and Cosmetic Act.”. [ii] 2030 , 2068, 2070; Pub. 2030 , 2068, 2070; Pub.
Expert insights. Personalized for you.
81 
Let's personalize your content